Replies to post #216442 on Biotech Values

[randychub]

I disagree. The major attribute that made it better then Botox was duration. I don’t think this set back changes that fact. I would agree that going after PF May have been a mistake if they were confident Rt002 lasted longer. In the future I hope they go after proven indication and bank on longer lasting